Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for periphera...
Leadership
Ryan J. Watts Ph.D.Founder
Co-Founder, President, CEO & Director
Alexander O. Schuth M.D., Ph.D.Founder
Co-Founder, CFO, COO & Secretary
Dana Andersen
Chief Technical and Manufacturing Officer
Joe Lewcock Ph.D.
Chief Scientific Officer
Chris Walsh J.D.
General Counsel
Cindy Dunkle
Chief People Officer
Katie Peng M.B.A.
Chief Commercial Officer
Peter Chin M.D.
Acting Chief Medical Officer & Head of Development
